TherapeuticsMD Inc (TXMD)

ENERGY: OIL & GAS PRODUCTION
SIC: PHARMACEUTICAL PREPARATIONS

951 YAMATO ROAD, SUITE 220 BOCA RATON, FL 33431

TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.

Data as of 2021-02-27 10:33:15 -0500
Market Cap455.643 Million Shares Outstanding299.765 Million Avg 30-day Volume22.36 Million
P/E Ratio-2.38717 Dividend Yield EPS-0.708
Price/Sales7.83 Debt to Equity-1.53 EBITDA-164.3 Million
Price to Book Value-3.93 Forward PE-4.58 Enterprise Value613.061 Million
Total Cash79.634 Million Current Debt47.33 Million Gross Profit44.923 Million
BETA1.61593 52-week High/Low2.75 / 0.853 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TXMD instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 157 142 10.56% 33 (1.99%) 30 (1.87%) 10.0%
13F shares: 160.589 Million 157.547 Million 1.93% 42.119 Million 31.941 Million 31.86%
% Ownership 53.5716 57.7493 -7.23% 14.0506 11.7081 20.01%
New Positions: 28 15 86.67% 8 5 60.0%
Increased Positions 45 32 40.63% 11 7 57.14%
Closed Positions 12 22 -45.45% 5 7 -28.57%
Reduced Positions 38 48 -20.83% 7 12 -41.67%
Total Calls 869.569 Thousand 1.107 Million -21.44% 338.9 Thousand 340.1 Thousand -0.35%
Total Puts 960.691 Thousand 981.252 Thousand -2.1% 112 Thousand 119.6 Thousand -6.35%
PUT/CALL Ratio 1.1 0.89 23.6% 0.33 0.35 -5.71%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TXMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TXMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MILLIGAN JOHN C.K. IV PRESIDENT/SECRETARY

  • Officer
0 2020-11-24 2

FINIZIO ROBERT G CEO

  • Officer
  • Director
0 2020-11-24 4

DONEGAN MICHAEL C CHIEF ACCOUNTING OFFICER

  • Officer
0 2020-11-24 2

BORKOWSKI EDWARD EXECUTIVE VICE PRESIDENT

  • Officer
0 2020-08-01 1

WALKER MARLAN D GENERAL COUNSEL

  • Officer
0 2020-08-01 1

COLLINS COOPER C.

  • Director
0 2020-06-18 2

RUSSELL ANGUS C.

  • Director
0 2020-06-18 1

CARROLL J MARTIN

  • Director
0 2020-06-18 1

MUSING JULES A.

  • Director
0 2020-06-18 1

THOMPSON TOMMY G

  • Director
0 2020-06-18 2

BISARO PAUL

  • Director
0 2020-06-18 3

NAUGHTON GAIL K

  • Director
0 2020-06-18 2

LING KAREN

  • Director
0 2020-06-18 2

DARECCA JAMES CHIEF FINANCIAL OFFICER

  • Officer
0 2020-06-18 3

KRASSAN MITCHELL CHIEF STRATEGY OFFICER

  • Officer
0 2020-03-30 1

CARTWRIGHT DANIEL A CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-30 1

BERNICK BRIAN

  • Director
6,658,371 2019-10-25 0

BARLOW JANE F

  • Director
3,144 2019-08-12 0

SEGAL NICHOLAS

  • Director
0 2019-06-20 0

LAPENTA ROBERT V JR

  • Director
0 2019-06-20 0

HOWES JEFFREY D

  • NONE
No longer subject to file 2011-10-04 0

CAMBRIDGE ROBERT

  • NONE
No longer subject to file 2011-02-15 0

MASTROPIETRO DONALD R

  • NONE
No longer subject to file 2010-12-17 0

TJON ROBIN NATALIE

  • NONE
No longer subject to file 2010-12-17 0

SARUBBI KIMBERLY

  • NONE
No longer subject to file 2010-12-17 0

RICHARDSON CHARLES V

  • Director
0 2009-08-14 0

KELLEY SKY B PRESIDENT, CEO

  • Officer
  • Director
  • 10% Owner
3,423,422 2009-07-27 0

GOLDEN ANDREW E

  • Director
0 2009-07-27 0

MANDEL RICHARD H JR

  • Director
13,100 2008-06-21 0

HAMILTON DAVID S

  • Director
0 2008-06-17 0

WOODHILL GREGORY PRESIDENT, SECRETARY, CFO

  • Officer
  • Director
0 2008-06-17 0

CHESTER MICHAEL

  • Director
0 2008-06-17 0

TERRACE LANE, LLC

  • 10% Owner
646,000 2008-06-17 0

JENSEN JULIAN D

  • Director
0 2008-06-17 0

JENSEN DEVELOPMENT CO FORMER PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2008-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
THERAPEUTICS MD INC TXMD 2021-02-26 22:15:02 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 21:45:03 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 21:15:02 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 20:45:03 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 20:15:03 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 19:45:03 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 19:15:03 UTC -1.4267 1.4967 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 18:45:03 UTC -1.4345 1.5045 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 18:15:02 UTC -1.4345 1.5045 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 17:45:02 UTC -1.4345 1.5045 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 17:15:03 UTC -1.4345 1.5045 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 16:45:03 UTC -1.4387 1.5087 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 16:15:02 UTC -1.4387 1.5087 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 15:45:03 UTC -1.4387 1.5087 3800000
THERAPEUTICS MD INC TXMD 2021-02-26 15:15:03 UTC -1.4387 1.5087 3900000
THERAPEUTICS MD INC TXMD 2021-02-26 14:45:03 UTC -2.1383 2.2083 3900000
THERAPEUTICS MD INC TXMD 2021-02-26 13:00:03 UTC -2.1383 2.2083 2200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments TXMD -116678.0 shares, $-142347.16 2020-10-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TXMD -900.0 shares, $-1422.0 2020-09-30 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund TXMD -159944.0 shares, $-195131.68 2020-10-31 N-PORT

Elevate your investments